Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Democrats oddly abet drug drive
- MERCK & Co. is a very large pharmaceutical company and it's Democratic Party dogma to attack drug companies for their large profit margins. That's why it was particularly odd when a very liberal Democratic legislator, Assemblywoman Sally Lieber of Mountain View, introduced a bill that would have...
- Research articles 2007-05-12
- Democrats oddly abet drug drive
- MERCK & Co. is a very large pharmaceutical company and its Democratic Party dogma to attack drug companies for their large profit margins. Thats why it was particularly odd when a very liberal Democratic legislator, Assemblywoman Sally Lieber of Mountain View, introduced a bill that would have...
- Research articles 2007-05-12
- Trexima relieves migraines, Gardasil gets nod from European Commission.
- M2 PRESSWIRE-28 September 2006-InvestSource Inc.: Trexima relieves migraines, Gardasil gets nod from European CommissionC1994-2006 M2 COMMUNICATIONS LTD RDATE:28092006 For more up to the minute industry updates, please visit www.investsourceinc.com On Wednesday Pfizer Incorporated (NYSE: PFE) announced a $15...
- Research articles 2006-09-28
- Merck & Co., Inc. Guidance Call Transcript
- Question-and-Answer Session Operator Thank you. Operator Instructions Your first question comes from Chris Schott - J.P. Morgan. Chris Schott - J.P. Morgan Just two quick questions. First, on GARDASIL, can you just talk a little bit more about the geographic mix of your consolidated sales? Given the...
- Earnings calls 2008-12-04
- Study Says Merck's Gardasil Is Safe, Vexing Media and Activists
- The CDC studied 370,000 doses of Merck's Gardasil vaccine for HPV and cervical cancer, and found that the drug is not linked to the risks that the media and conservative activists say it is. The news will come as a frustration to the growing body of Americans who believe that...
- Blog posts 2008-10-23
- Journal Uses Out-of-Date Info to Bash Merck's Gardasil
- Pharmalot and the Wall Street Journal both used outdated information in items they published on Merck's Gardasil today. That's a shame, because having accurate, up-to-date information is crucial in sorting fact from squeamishness about the controversial HPV vaccine that is now mandatory for many schoolgirls. The WSJ and Pharmalot pointed...
- Blog posts 2008-11-12
- FDA Study Says Merck's Gardasil Is Safe, Vexing Media and Activists
- FDA Study Says Merck's Gardasil Is Safe, Vexing Media and ActivistsRE: FDA Study Says Merck's Gardasil Is Safe, Vexing Media and ActivistsAnd what do you say to Dr. Diane Harper? Is merck not also responsible for Vioxx? After the vioxx and paxil scandals who in the name of god...
- Discussion threads 2008-10-23
Additional Resources
- Merck asks FDA to expand Gardasil use
- Anyone who's been following the vaccine trade knows that Merck is working hard to expand the use of its human papillomavirus shot. Now approved for marketing to girls and young women, Gardasil has been tested on boys, young men and on women as old as 45, with the aim of...
- News items 2009-08-07
- Cervarix gets CDC nod; Gardasil-for-boys slighted
- The HPV vaccine saga continues. Less than a week after we got the FDA nod on GlaxoSmithKline's Cervarix shot and a new use in males for Merck's Gardasil, the Centers for Disease Control and Prevention has weighed in. And though the public-health agency sided with FDA on Cervarix, it wasn't...
- News items 2009-10-22
- Merck reassigns Gardasil exec
- Sometimes in business journalism we overlook the fact that every deal, every drug approval, every sales decline isn't some abstract event, but one engineered and caused by, lamented or celebrated, by individual people. When the story is a layoff, the impact on individuals is clear. Not so much a "Complete...
- News items 2009-08-07
- Gardasil-TM-, Merck's Investigational Cervical Cancer Vaccine, Produced High Anti-HPV Immune Response in Adolescents; Newest Data on Gardasil-TM- Presented at European Society of Pediatric Infectious Diseases
- VALENCIA, Spain -- GardasilTM, Merck & Co., Inc.'s investigational quadrivalent human papillomavirus HPV vaccine, produced higher anti-HPV immune responses among adolescent males and females compared to young women, according to a new study presented today. Gardasil is an investigational vaccine designed to prevent infection from four common HPV types -...
- Research articles 2005-05-19
- New England Journal of Medicine Publishes New Data on GARDASIL®, Merck's Cervical Cancer Vaccine
- WHITEHOUSE STATION, N.J. -- May 10, 2007--Today, the New England Journal of Medicine is publishing results from two Phase III studies of Merck's cervical cancer vaccine, GARDASIL (Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine). In the first study, GARDASIL provided 100 percent protection against cervical, vaginal and...
- Research articles 2007-05-09
- Merck's Charm Offensive for Gardasil
- Mike Huckman submits: In the current monster-sized issue of Vogue, my producer, Ruth, while killing time on the Delta shuttle on our way from New York to Boston for a shoot this week, uncovered a blogworthy story buried in the hundreds and hundreds and hundreds of pages of fashion...
- External links 2008-08-29
- Media Gearing Up for Merck's 'Gardasil for Boys' Campaign
- BNET suggested recently that Merck's Gardasil anti-HPV vaccine had mostly tapped the sweet spot of its revenues -- preteen girls -- and was thus moving on to populations where the vaccine is much less beneficial. There is almost no point in giving the vaccine to women aged 29-45 who are...
- Blog posts 2008-11-14
- Dissecting Merck's "Gardasil for Boys" FDA Application
- Merck has filed an application with the FDA for the use of the HPV vaccine Gardasil in boys. The move was predicted by BNET on Nov. 14. It will likely spur two debates, one over the safety of the vaccine and another over whether Gardasil is actually cost-effective enough to...
- Blog posts 2009-01-06
- Is Merck's Gardasil Linked To Lou Gehrig's Disease?
- Merck's Gardasil made big news late last week - and it wasn't all good. First, the FDA endorsed the vaccine to thwart genital warts in boys and young men. This is a mild plus for the drugmaker; Gardasil is already approved to ward off the human papillomavirus, or HPV, in...
- News items 2009-10-22
- Merck's Cervical Cancer Vaccine, GARDASIL®, Added to the CDC Vaccines for Children Contract
- WHITEHOUSE STATION, N.J. -- Merck & Co., Inc. today announced that the U.S. Centers for Disease Control and Prevention CDC has added Merck's cervical cancer vaccine, GARDASIL( [R] ) [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine] to the CDC's Vaccines for Children VFC contract for girls and...
- Research articles 2006-11-01
- Merck Submits New Cross-Protection Data for GARDASIL® to the FDA and Seeks New Indications for Vaginal and Vulvar Cancers
- WHITEHOUSE STATION, N.J. -- Merck announced today the Company has submitted a supplemental Biologics License Application sBLA for GARDASIL([R]) [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine] to the U.S. Food and Drug Administration FDA to update the labeling for GARDASIL, the cervical cancer vaccine. The new submission...
- Research articles 2007-04-17
- Gardasil in Decline, Merck Now Increasingly Dependent on Januvia
- Merck CEO Richard Clark says he cannot "categorically rule out" an acquisition despite a slight uptick in net income, according to the WSJ. You bet he can't. A look at Merck's income statement shows that the company is increasingly dependent on a single drug -- diabetes treatment Januvia -- and...
- Blog posts 2009-02-04
- Merck Submits Biologics License Application to FDA for GARDASIL®, the Company's Investigational Vaccine for Cervical Cancer
- WHITEHOUSE STATION, N.J. -- Merck & Co., Inc. announced today that the Company submitted a Biologics License Application BLA for GARDASILR (quadrivalent human papillomavirus types 6, 11, 16, 18, recombinant vaccine) to the U.S. Food and Drug Administration FDA on December 1, 2005. Merck also announced that it has plans...
- Research articles 2005-12-05
- << Previous
- page 1 of 1
- Next >>
